- Home
- CRGX vs TRST Comparison
CRGX vs TRST Comparison
Compare CRGX & TRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- TRST
- Stock Information
- Founded
- CRGX 2021
- TRST 1902
- Country
- CRGX United States
- TRST United States
- Employees
- CRGX N/A
- TRST N/A
- Industry
- CRGX
- TRST Major Banks
- Sector
- CRGX
- TRST Finance
- Exchange
- CRGX Nasdaq
- TRST Nasdaq
- Market Cap
- CRGX 190.0M
- TRST 669.9M
- IPO Year
- CRGX 2023
- TRST N/A
- Fundamental
- Price
- CRGX $4.61
- TRST $34.53
- Analyst Decision
- CRGX Hold
- TRST
- Analyst Count
- CRGX 7
- TRST 0
- Target Price
- CRGX $5.33
- TRST N/A
- AVG Volume (30 Days)
- CRGX 2.0M
- TRST 92.5K
- Earning Date
- CRGX 08-11-2025
- TRST 07-21-2025
- Dividend Yield
- CRGX N/A
- TRST 4.17%
- EPS Growth
- CRGX N/A
- TRST N/A
- EPS
- CRGX N/A
- TRST 2.68
- Revenue
- CRGX N/A
- TRST $173,999,000.00
- Revenue This Year
- CRGX $57.81
- TRST $13.13
- Revenue Next Year
- CRGX N/A
- TRST N/A
- P/E Ratio
- CRGX N/A
- TRST $13.17
- Revenue Growth
- CRGX N/A
- TRST N/A
- 52 Week Low
- CRGX $3.00
- TRST $27.18
- 52 Week High
- CRGX $25.45
- TRST $38.89
- Technical
- Relative Strength Index (RSI)
- CRGX 61.57
- TRST 66.47
- Support Level
- CRGX $4.32
- TRST $34.27
- Resistance Level
- CRGX $4.63
- TRST $35.59
- Average True Range (ATR)
- CRGX 0.15
- TRST 0.74
- MACD
- CRGX 0.04
- TRST 0.08
- Stochastic Oscillator
- CRGX 76.44
- TRST 79.36
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.